Denali Therapeutics Inc. (DNLI)
NASDAQ · Healthcare
Denali Therapeutics Inc. Shareholder Equity 2016–2025
Denali Therapeutics Inc. annual/quarterly shareholder equity history from 2017 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Denali Therapeutics Inc. shareholder equity for the quarter ending December 31, 2025 were 1.01B, a 17.56% decrease year-over-year.
- Denali Therapeutics Inc. shareholder equity for 2025 were 1.01B, a 17.56% decrease from 2024.
- Denali Therapeutics Inc. shareholder equity for 2024 were 1.23B, a 19.28% increase from 2023.
- Denali Therapeutics Inc. shareholder equity for 2023 were 1.03B, a 1.10% decrease from 2022.
- Denali Therapeutics Inc. shareholder equity for 2022 were 1.04B.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Denali Therapeutics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $1,014 |
| 2024 | $1,230 |
| 2023 | $1,031 |
| 2022 | $1,042 |
| 2021 | $962 |
| 2020 | $1,151 |
| 2019 | $395 |
| 2018 | $547 |
| 2017 | $466 |
| Denali Therapeutics Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $1,014 |
| 2024-12-31 | $1,230 |
| 2023-12-31 | $1,031 |
| 2022-12-31 | $1,042 |
| 2021-12-31 | $962 |
| 2020-12-31 | $1,151 |
| 2019-12-31 | $395 |
| 2018-12-31 | $547 |
| 2017-12-31 | $466 |
Denali Therapeutics Inc. Shareholder Equity — FAQ
Denali Therapeutics Inc. (DNLI) shareholder equity over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see DNLI's shareholder equity history?
The chart and table above show Denali Therapeutics Inc.'s shareholder equity by year and by quarter, including the growth rate.